Production (Stage)
E
Marker Therapeutics, Inc. MRKR
$1.77 $0.2516.45% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Total Cash And Short-Term Investments -28.65% 113.26% 15.37% -31.11% -25.07%
Total Receivables 4.78% 215.25% -70.11% 34.49% 80.14%
Inventory -- -- -- -- --
Prepaid Expenses 73.93% -58.53% -15.75% 50.97% -7.20%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -22.84% 101.85% -6.55% -17.15% -17.72%

Total Current Assets -22.84% 101.85% -6.55% -17.15% -17.72%
Net Property, Plant & Equipment -- -- -- -- --
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -- -- -- -- --
Total Assets -22.84% 101.85% -6.55% -17.15% -17.72%

Total Accounts Payable 21.68% -44.01% 75.97% -9.96% 25.05%
Total Accrued Expenses -54.40% 62.07% 242.63% -27.52% -71.45%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -- --
Total Finance Division Other Current Liabilities -0.49% 0.84% -58.95% -11.10% 171.44%
Total Other Current Liabilities -0.49% 0.84% -58.95% -11.10% 171.44%
Total Current Liabilities -27.80% 0.11% 75.48% -14.39% -25.08%

Total Current Liabilities -27.80% 0.11% 75.48% -14.39% -25.08%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities -27.80% 0.11% 75.48% -14.39% -25.08%

Common Stock & APIC 0.08% 3.32% 0.01% 0.02% 0.03%
Retained Earnings -0.99% -0.87% -0.52% -0.50% -0.55%
Treasury Stock & Other -- -- -- -- --
Total Common Equity -21.91% 149.12% -23.22% -17.69% -16.11%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity -21.91% 149.12% -23.22% -17.69% -16.11%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity -21.91% 149.12% -23.22% -17.69% -16.11%